Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenomatous Polyposis Coli × Azithromycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

COVID-19 2 Skin Neoplasms 1 Respiratory Sounds 1 Respiratory Distress Syndrome 1 Pneumonia, Viral 1 Neoplasms 1 Lymphoma, Follicular 1 Hematologic Neoplasms 1 Cytokine Release Syndrome 1 Asthma 1 Adenomatous Polyposis Coli 1

Interventions

Celecoxib 6 Biopsy 5 Sulindac 4 Specimen Handling 3 Eflornithine 3 Ursodeoxycholic Acid 2 Surveys and Questionnaires 2 Sirolimus 2 Sigmoidoscopy 2 Gastroscopy 2 Erythromycin 2 Erlotinib Hydrochloride 2 Endoscopy, Gastrointestinal 2 Endoscopy, Digestive System 2 Curcumin 2 rofecoxib 1 obeticholic acid 1 guselkumab 1 Thiamine 1 Surgical Procedures, Operative 1 Probiotics 1 Pharmaceutical Preparations 1 Niclosamide 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Inulin 1 Immunohistochemistry 1 Exercise Therapy 1 Endoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04454151 2020-07-01

FAP

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown

Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡